The Combination Neuroprotective Abilities of Resveratrol and Naringenin in Attenuation of Sleep Deprivation Complications in Rats

Authors

  • Hamid Zaferani Arani 2. Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  • Zahra Abbasy 1. Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran
  • Hesam Adin Atashi 2. Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  • Felicia Agatha 3. Senior High School Student, Tzu Chi Secondary School PIK, DKI Jakarta, Indonesia
  • Fatemeh Mirparsa 4. Midwifery Undergraduate and Master Student of Health Services Management, Department of Health Care Management, Faculty of Health, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  • Amirhossein Gaeini 5. Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy
  • Atousa Hashemi 6. Department of Molecular Medicine, University of Padua, Padua, Italy

DOI:

https://doi.org/10.31661/gmj.v10i.2315

Keywords:

Combination Effects, Resveratrol, Naringenin, Sleep Deprivation

Abstract

Background: Sleep loss is one of the most important health problems in the world, and about 30 to 40 percent of ordinary people suffer from it. This study aimed to investigate the neuroprotective effects of the combination of resveratrol and naringenin in attenuation of sleep deprivation (SD) complications in rats. Materials and Methods: In this experimental study, 72 Wistar male rats were randomly divided into three main groups, including control, sham, and 7-days SD group. Each of its main groups consisted of three subgroups, including without drug, vehicle, and combination therapy groups (naringenin [100 mg/kg], resveratrol [100 mg/kg]). The day after the latest injection, the fear conditioning memory tests, locomotor activity test, hot plate, and forced swimming tests (FST) were carried out on all rats, and then sham and SD groups were induced 48 hours of non-REM SD (device off and on, respectively) and these behavioral tests were repeated for all rats again. Finally, the brains of all rats were removed and histopathologically examined, and stained with nissl and TUNNEL. Results: To assess fear condition memory, the rate of latency to first freezing in the visual and auditory phase increased in sham and SD rats that received vehicle or no drug (P<0.001), which indicates memory corruption. Injection of the combination of naringenin and resveratrol reduced the latency to first freezing (P<0.001), which means improved memory. In the FST test, injection of naringenin and resveratrol reduced the rate of immobility (P<0.001), which means improved depressive behavior. The naringenin and resveratrol reduced the pain perception threshold. Also, the naringenin and resveratrol reduced apoptosis compared to the control and vehicle groups (P<0.001). Conclusions: The combination of naringenin and resveratrol compared to other groups could improve memory and mood as well as reduce apoptosis, depression, and pain perception threshold. [GMJ.2021;10:e2315]

References

Libman E, Fichten C, Creti L, Conrod K, Tran DL, Grad R, et al. Refreshing sleep and sleep continuity determine perceived sleep quality. Sleep Disord. 2016;2016:7170610. https://doi.org/10.1155/2016/7170610PMid:27413553 PMCid:PMC4927978 Nikfar B, Moazzami B, Chaichian S, Ghalichi L, Ekhlasi-Hundrieser M, Chashmyazdan M, et al. Sleep Quality and its Main Determinants Among Staff in a Persian Private Hospital. Arch Iran Med. 2018;21(11):524-9. Eide PK, Vinje V, Pripp AH, Mardal KA, Ringstad G. Sleep deprivation impairs molecular clearance from the human brain. Brain. 2021;144(3):863-74. https://doi.org/10.1093/brain/awaa443PMid:33829232 Liew SC, Aung T. Sleep deprivation and its association with diseases-a review. Sleep Med. 2021;77:192-204. https://doi.org/10.1016/j.sleep.2020.07.048PMid:32951993 Alimohammadzadeh K, Akhlaghdoust M, Bahrainian S A, Mirzaei A. Survey on Mental Health of Iranian Medical Students: A Cross- sectional Study in Islamic Azad University, Shiraz E-Med J. 2017;18(7):e14929. https://doi.org/10.5812/semj.14929 Cross N, Paquola C, Pomares FB, Perrault AA, Jegou A, Nguyen A, et al. Cortical gradients of functional connectivity are robust to state-dependent changes following sleep deprivation. Neuroimage. 2021;226:117547. https://doi.org/10.1016/j.neuroimage.2020.117547PMid:33186718 Cherubini JM, Cheng JL, Williams JS, MacDonald MJ. Sleep deprivation and endothelial function: reconciling seminal evidence with recent perspectives. Am J Physiol Heart Circ. 2021;320(1):29-35. https://doi.org/10.1152/ajpheart.00607.2020PMid:33064569 Chai Y, Fang Z, Yang FN, Xu S, Deng Y, Raine A, et al. Two nights of recovery sleep restores hippocampal connectivity but not episodic memory after total sleep deprivation. Sci Rep. 2020;10(1):1-1. https://doi.org/10.1038/s41598-020-65086-xPMid:32472075 PMCid:PMC7260173 Bishir M, Bhat A, Essa MM, Ekpo O, Ihunwo AO, Veeraraghavan VP, et al. Sleep deprivation and neurological disorders. Biomed Res Int. 2020; 2020:5764017. https://doi.org/10.1155/2020/5764017PMid:33381558 PMCid:PMC7755475 Vishwakarma LC, Sharma B, Singh V, Jaryal AK, Mallick HN. Acute sleep deprivation elevates brain and body temperature in rats. J Sleep Res. 2021;30(2):e13030. https://doi.org/10.1111/jsr.13030PMid:32297401 Joshi R, Kulkarni YA, Wairkar S. Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update. Life sci. 2018;215:43-56. https://doi.org/10.1016/j.lfs.2018.10.066PMid:30391464 Fourny N, Lan C, Sérée E, Bernard M, Desrois M. Protective effect of resveratrol against ischemia-reperfusion injury via enhanced high energy compounds and eNOS-SIRT1 expression in type 2 diabetic female rat heart. Nutrients. 2019;11(1):105. https://doi.org/10.3390/nu11010105PMid:30621358 PMCid:PMC6356423 Tutunchi H, Naeini F, Ostadrahimi A, Hosseinzadehâ€Attar MJ. Naringenin, a flavanone with antiviral and antiâ€inflammatory effects: A promising treatment strategy against COVIDâ€19. Phytother Res. 2020;34(12):3137-47. https://doi.org/10.1002/ptr.6781PMid:32613637 PMCid:PMC7361426 Zeng W, Jin L, Zhang F, Zhang C, Liang W. Naringenin as a potential immunomodulator in therapeutics. Pharmacol Res. 2018;135:122-6. https://doi.org/10.1016/j.phrs.2018.08.002PMid:30081177 Said RS, Mantawy EM, El-Demerdash E. Mechanistic perspective of protective effects of resveratrol against cisplatin-induced ovarian injury in rats: emphasis on anti-inflammatory and anti-apoptotic effects. Naunyn Schmiedebergs Arch Pharmacol. 2019;392(10):1225-38. https://doi.org/10.1007/s00210-019-01662-xPMid:31129703 Clementi N, Scagnolari C, D'Amore A, Palombi F, Criscuolo E, Frasca F, et al. Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro. Pharmacol Res. 2020; 163:105255. https://doi.org/10.1016/j.phrs.2020.105255PMid:33096221 PMCid:PMC7574776 Meng T, Xiao D, Muhammed A, Deng J, Chen L, He J. Anti-inflammatory action and mechanisms of resveratrol. Molecules. 2021;26(1):229. https://doi.org/10.3390/molecules26010229PMid:33466247 PMCid:PMC7796143 Arafah A, Rehman MU, Mir TM, Wali AF, Ali R, Qamar W, et al. Multi-therapeutic potential of naringenin (4′, 5, 7-trihydroxyflavonone): experimental evidence and mechanisms. Plants (Basel). 2020;9(12):1784. https://doi.org/10.3390/plants9121784PMid:33339267 PMCid:PMC7766900 Chin LH, Hon CM, Chellappan DK, Chellian J, Madheswaran T, Zeeshan F, et al. Molecular mechanisms of action of naringenin in chronic airway diseases. Eur J Pharmacol. 2020;879:173139. https://doi.org/10.1016/j.ejphar.2020.173139PMid:32343971 Leenaars CH, Joosten RN, Zwart A, Sandberg H, Ruimschotel E, Hanegraaf MA, et al. Switch-task performance in rats is disturbed by 12 h of sleep deprivation but not by 12 h of sleep fragmentation. Sleep. 2012;35(2):211-21. https://doi.org/10.5665/sleep.1624PMid:22294811 PMCid:PMC3250360 Khajevand-Khazaei MR, Ziaee P, Motevalizadeh SA, Rohani M, Afshin-Majd S, Baluchnejadmojarad T, et al. Naringenin ameliorates learning and memory impairment following systemic lipopolysaccharide challenge in the rat. Eur J Pharmacol. 2018;826:114-22. https://doi.org/10.1016/j.ejphar.2018.03.001PMid:29518393 Singh N, Agrawal M, DoreÌ S. Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models. ACS Chem Neurosci. 2013;4(8):1151-62. https://doi.org/10.1021/cn400094wPMid:23758534 PMCid:PMC3750679 Raj J, Chandra M, Dogra TD, Pahuja M, Raina A. Determination of median lethal dose of combination of endosulfan and cypermethrin in wistar rat. Toxicol Int. 2013;20(1):1. https://doi.org/10.4103/0971-6580.111531PMid:23833430 PMCid:PMC3702116 Leenaars CH, Joosten RN, Zwart A, Sandberg H, Ruimschotel E, Hanegraaf MA, et al. Switch-task performance in rats is disturbed by 12 h of sleep deprivation but not by 12 h of sleep fragmentation. Sleep. 2012;35(2):211-21. https://doi.org/10.5665/sleep.1624PMid:22294811 PMCid:PMC3250360 Campbell TL, Kochli DE, McDaniel MA, Myers MK, Dunn ME, Diana VA, et al. Using Extinction-Renewal to Circumvent the Memory Strength Boundary Condition in Fear Memory Reconsolidation. Brain Sci. 2021;11(8):1023. https://doi.org/10.3390/brainsci11081023PMid:34439642 PMCid:PMC8393283 Moreno-Santos B, Marchi-Coelho C, Costa-Ferreira W, Crestani CC. Angiotensinergic receptors in the medial amygdaloid nucleus differently modulate behavioral responses in the elevated plus-maze and forced swimming test in rats. Behav Brain Res. 2021;397:112947. https://doi.org/10.1016/j.bbr.2020.112947PMid:33011187 Hazim AI, Ramanathan S, Parthasarathy S, Muzaimi M, Mansor SM. Anxiolytic-like effects of mitragynine in the open-field and elevated plus-maze tests in rats. J Physiol Sci. 2014;64(3):161-9. https://doi.org/10.1007/s12576-014-0304-0PMid:24464759 Bai Y, Peng W, Yang C, Zou W, Liu M, Wu H, et al. Pharmacokinetics and metabolism of naringin and active metabolite naringenin in rats, dogs, humans, and the differences between species. Front Pharmacol. 2020;11:364. https://doi.org/10.3389/fphar.2020.00364PMid:32292344 PMCid:PMC7118210 Radmansouri M, Ghiasvand S, Shahriari F, Aryan H, Jangholi E, Javidi MA. Hypericin Induces Apoptosis in MDA-MB-175-VII Cells in Lower Dose Compared to MDA-MB-231. Archives of Iranian Medicine. 2018;21(9):387-92. Liaquat L, Batool Z, Sadir S, Rafiq S, Shahzad S, Perveen T, et al. Naringenin-induced enhanced antioxidant defence system meliorates cholinergic neurotransmission and consolidates memory in male rats. Life Sci. 2018;194:213-23. https://doi.org/10.1016/j.lfs.2017.12.034PMid:29287782 Liao D, Lv C, Cao L, Yao D, Wu Y, Long M, et al. Curcumin Attenuates Chronic Unpredictable Mild Stress-Induced Depressive-Like Behaviors via Restoring Changes in Oxidative Stress and the Activation of Nrf2 Signaling Pathway in Rats. Oxid Med Cell Longev. 2020;2020:9268083. https://doi.org/10.1155/2020/9268083PMid:33014280 PMCid:PMC7520007 Guo Y, Gan X, Zhou H, Zhou H, Pu S, Long X, et al. Fingolimod suppressed the chronic unpredictable mild stress-induced depressive-like behaviors via affecting microglial and NLRP3 inflammasome activation. Life Sci. 2020;263:118582. https://doi.org/10.1016/j.lfs.2020.118582PMid:33058911 Khan H, Ullah H, Tundis R, Belwal T, Devkota H, Daglia M, et al. Dietary Flavonoids in the Management of Huntington's Disease: Mechanism and Clinical Perspective. eFood. 2020;1(1):38-52. https://doi.org/10.2991/efood.k.200203.001 Hua FZ, Ying J, Zhang J, Wang XF, Hu YH, Liang YP, et al. Naringenin pre-treatment inhibits neuroapoptosis and ameliorates cognitive impairment in rats exposed to isoflurane anesthesia by regulating the PI3/Akt/PTEN signalling pathway and suppressing NF-kappaB-mediated inflammation. Int J Mol Med. 2016;38(4):1271-80. https://doi.org/10.3892/ijmm.2016.2715PMid:27572468 Ghofrani S, Joghataei MT, Mohseni S, Baluchnejadmojarad T, Bagheri M, Khamse S, et al. Naringenin improves learning and memory in an Alzheimer's disease rat model: Insights into the underlying mechanisms. Eur J Pharmacol. 2015;764:195-201. https://doi.org/10.1016/j.ejphar.2015.07.001PMid:26148826 Tayyab M, Farheen S, M MMP, Khanam N, Mobarak Hossain M, Shahi MH. Antidepressant and Neuroprotective Effects of Naringenin via Sonic Hedgehog-GLI1 Cell Signaling Pathway in a Rat Model of Chronic Unpredictable Mild Stress. Neuromolecular Med. 2019;21(3):250-61. https://doi.org/10.1007/s12017-019-08538-6PMid:31037465 Rezaie M, Nasehi M, Vaseghi S, Alimohammadzadeh K, Islami Vaghar M, Mohammadi-Mahdiabadi-Hasani MH, et al. The interaction effect of sleep deprivation and cannabinoid type 1 receptor in the CA1 hippocampal region on passive avoidance memory, depressive-like behavior and locomotor activity in rats. Behav Brain Res. 2021;396:112901. https://doi.org/10.1016/j.bbr.2020.112901PMid:32920013 Chen L, Wang Z, Wang XM. Rapid eye-movement sleep for five days deprivation causes delayed depressive-like behavior in mice. South Med J. 2016;36(5):660-4. Yi LT, Liu BB, Li J, Luo L, Liu Q, Geng D, et al. BDNF signaling is necessary for the antidepressant-like effect of naringenin. Prog Neuropsychopharmacol Biol Psychiatry. 2014; 48:135-41. https://doi.org/10.1016/j.pnpbp.2013.10.002PMid:24121063 Arora S, Venugopalan A, Dharavath RN, Bishnoi M, Kondepudi KK, Chopra K. Naringenin Ameliorates Chronic Sleep Deprivation-Induced Pain via Sirtuin 1 Inhibition. Neurochem Res. 2021;46(5):1177-87. https://doi.org/10.1007/s11064-021-03254-9PMid:33599956 Javad-Moosavi BZ, Nasehi M, Vaseghi S, Jamaldini SH, Zarrindast MR. Activation and Inactivation of Nicotinic Receptnors in the Dorsal Hippocampal Region Restored Negative Effects of Total (TSD) and REM Sleep Deprivation (RSD) on Memory Acquisition, Locomotor Activity and Pain Perception. Neuroscience. 2020;433:200-11. https://doi.org/10.1016/j.neuroscience.2020.03.006PMid:32200080 Eydipour Z, Nasehi M, Vaseghi S, Jamaldini SH, Zarrindast MR. The role of 5-HT4 serotonin receptors in the CA1 hippocampal region on memory acquisition impairment induced by total (TSD) and REM sleep deprivation (RSD). Physiol Behav. 2020;215:112788. https://doi.org/10.1016/j.physbeh.2019.112788PMid:31863855 Eisenach JC, Hood DD, Curry R, Sawynok J, Yaksh TL, Li X. Intrathecal but not intravenous opioids release adenosine from the spinal cord. J Pain. 2004;5(1):64-8. https://doi.org/10.1016/j.jpain.2003.10.001PMid:14975380

Published

2021-12-31

Issue

Section

Original Article